Side-by-side comparison of AI visibility scores, market position, and capabilities
Healthcare AI automating prior authorization documentation by reviewing patient records; $13.1M from General Catalyst and YC achieving $2.4M revenue competing with Cohere Health for pharmacy workflow automation.
Latent is a San Francisco-based healthcare AI company automating clinical operations for pharmacy and medication access workflows — using AI to review patient medical records, generate evidence-based prior authorization documentation, and streamline the clinical justification process that currently requires pharmacists and clinical staff to spend significant time on administrative documentation that delays patients' access to medications. Founded in 2022 and a Y Combinator W23 graduate, Latent raised $13.1 million from General Catalyst and Y Combinator, achieving $2.4 million in revenue in 2024.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.